GILD
Gilead Sciences, Inc (GILD) Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology Pipeline
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Gilead Extends Tender Offer to Acquire Arcellx
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 M&A Release
Gilead Sciences, Inc (GILD) Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Q4 2025 Earnings Call Transcript
Gilead Sciences, Inc (NASDAQ: GILD) Q4 2025 Earnings Call dated Feb. 10, 2026 Corporate Participants: Jacquie Ross — Senior Vice…
Gilead Sciences, Inc (GILD) Gilead Foundation Awards $12 Million to Empower Community Health Workers and Expand HIV Prevention Initiatives Across 14 States and the District of Columbia
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Sec Form 10K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 10K
Gilead Sciences, Inc (GILD) Gilead’s Single-Tablet Regimen of Bictegravir and Lenacapavir Maintained Virological Suppression in People With HIV Who Switched Antiretroviral Therapy
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release
Gilead Sciences, Inc (GILD) Sec Form 8K
Gilead Sciences, Inc (NASDAQ: GILD) Sec Form 8K
Gilead Sciences, Inc (GILD) Barclays Annual Global Healthcare Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference
Gilead Sciences, Inc (GILD) Leerink Partners Global Healthcare Conference
Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Corporate Conference